Portal Vein Thrombosis Clinical Trial
Official title:
Comparison in Portal Flow After Sleeve Gastrectomy and Mini Gastric Bypass
Obesity if a health endemic problem over the entire world. Bariatric surgery is the best
chance for those patients with morbid obesity to loss weight and to maintain the loosed
weight.
Metabolic surgery is the new name for bariatric surgery like sleeve gastrectomy and gastric
by pass due to the recognized changes in the homeostasis of the hormonal secretion responsive
to the hunger status. After sleeve gastrectomy we observe many patients with thrombus of the
portal vein system. This phenomena may be attributed to changes in the portal flow due to
devascularization of the great curvature of the stomach.
The aim of the study is to compare the portal flow by intra-operative Doppler ultrasound
before and after surgery of the two procedures as sleeve gastrectomy and gastric bypass, were
the vascularization is not changed by the surgery.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT03631147 -
The Effect of Rifaximin on Portal Vein Thrombosis
|
N/A | |
Completed |
NCT02250391 -
Placebo-controlled Study of NPB-06 in Patients With Portal Vein Thrombosis
|
Phase 3 | |
Recruiting |
NCT05625893 -
Proton Beam Radiotherapy Followed by Tecentriq and Avastin for Primary Liver Cancer With Vp2-4 Portal Vein Invasion
|
Phase 2 | |
Completed |
NCT05012501 -
Analysis of Neutrophil Extracellular Traps in Hypercoagulability and Portal Vein Thrombosis in Liver Cirrhosis Patients
|
||
Terminated |
NCT00769873 -
Anticoagulation Post Laparoscopic Splenectomy
|
Phase 2 | |
Recruiting |
NCT05123326 -
Global Coagulation Assessment in Portal Vein Thrombosis and Budd-Chiari Syndrome
|
||
Completed |
NCT01095185 -
Efficacy of Statin Association With Standard Treatment in Prevention of Recurrent Hemorrhage in Patient With Cirrhosis and Variceal Bleeding
|
Phase 3 | |
Completed |
NCT02585713 -
Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism
|
Phase 3 | |
Not yet recruiting |
NCT06117488 -
Risk Factors and Management Outcome of Chronic Portal Vein Thrombosis in Children
|
||
Completed |
NCT01326949 -
Transjugular Intrahepatic Portosystemic Shunt (TIPS) for Prevention of Variceal Rebleeding in Cirrhotic Patients With Portal Vein Thrombosis
|
N/A | |
Not yet recruiting |
NCT05339581 -
IMRT Plus PD-1 Blockade and Lenvatinib for HCC With PVTT (Vp3) Before Liver Transplantation
|
N/A | |
Recruiting |
NCT03902678 -
Role of EUS Guided FNA of Portal Vein Thrombus in the Diagnosis and Staging of Hepatocellular Carcinoma
|
N/A | |
Not yet recruiting |
NCT06319131 -
Nadroparin Versus TIPS in Cirrhotic Patients With Refractory Asymptomatic PVT
|
N/A | |
Recruiting |
NCT03193502 -
Efficacy and Safety of Rivaroxaban in the Management of Acute Non-neoplastic PVT Compensated Cirrhosis
|
Phase 3 | |
Completed |
NCT03201367 -
Efficacy and Safety of Rivaroxaban in Acute Non-neoplastic Portal Vein Thrombosis in HCV
|
N/A | |
Completed |
NCT03477149 -
EASYX-1 : A Multicenter Study on Safety and Efficacy of Easyx Liquid Embolization Agent Used in Five Separate Indications
|
N/A | |
Recruiting |
NCT02398357 -
The Effect of Anticoagulation After Endoscopic Therapy in Cirrhotic Patients With Portal Vein Thrombosis
|
Phase 4 | |
Completed |
NCT01556282 -
TheraSpheres Treatment for Unresectable Hepatocarcinoma and Portal Vein Thrombosis
|
N/A | |
Withdrawn |
NCT01631877 -
Efficacy and Safety of Acenocoumarol for Treatment of Nontumor Portal Vein Thrombosis in Cirrhosis of Liver
|
N/A | |
Recruiting |
NCT04433481 -
Efficacy and Safety of Dabigatran in Patients With Cirrhosis and Portal Vein Thrombosis
|
N/A |